(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 9.74% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.43%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.99%.
Mdxhealth Sa's revenue in 2026 is $108,084,000.On average, 8 Wall Street analysts forecast MDXH's revenue for 2026 to be $5,820,627,406, with the lowest MDXH revenue forecast at $5,537,095,256, and the highest MDXH revenue forecast at $6,083,613,749. On average, 8 Wall Street analysts forecast MDXH's revenue for 2027 to be $6,591,608,852, with the lowest MDXH revenue forecast at $6,040,467,552, and the highest MDXH revenue forecast at $7,183,841,767.
In 2028, MDXH is forecast to generate $7,329,717,004 in revenue, with the lowest revenue forecast at $6,594,177,078 and the highest revenue forecast at $7,874,180,916.